Sign in
4

Changes in Ownership

Enliven Therapeutics, Inc. Filed Acc 0001415889-24-025381

Director sold 1,270 shares at $27.67 ($35,143)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Heyman Richard A. · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-10-15 Sale : show line 1 in the form 10b5-1 −1,270 $27.67 $35,143 124,490 D
Open-market sales · 1,270 sh · avg $27.67 · $35,143
Loading xslF345X05/form4-10172024_091039.xml…